Publicacions destacades

Frequency and Characterization of Movement Disorders in Anti-IgLON5 Disease

Gaig C; Compta Y; Heidbreder A; Marti MJ; Titulaer MJ;

(...)

Sabater L; Iranzo A; Cano JS; Dalmau J; Graus F .

Referència:
Neurology 2021.
Encephalitis with Autoantibodies against the Glutamate Kainate Receptors GluK2

Landa, J; Guasp, M; Miguez-Cabello, F; Guimaraes, J; Mishima, T;

(...)

Gasull, X; Soto, D; Graus, F; Sabater, L; Dalmau, J.

Referència:
Annals Of Neurology 2021.
Clinical, Neuroimmunologic, and CSF Investigations in First Episode Psychosis

Guasp M; Giné-Servén E; Maudes E; Rosa-Justicia M; Martínez-Hernández E;

(...)

Saiz A; Graus F; Castro-Fornieles J; Parellada E; Dalmau J .

Referència:
Neurology 2021.
Placental transfer of NMDAR antibodies causes reversible alterations in mice

García-Serra A; Radosevic M; Pupak A; Brito V; Ríos J;

(...)

Pedreño M; Joubert B; Ginés S; Planagumà J; Dalmau J .

Referència:
Neurology-Neuroimmunology & Neuroinflammation 2021.
Sleep disorders in autoimmune encephalitis

Muñoz-Lopetegi A; Graus F; Dalmau J; Santamaria J;

Referència:
Lancet Neurology 2020.
Allosteric modulation of NMDA receptors prevents the antibody effects of patients with anti-NMDAR encephalitis

Mannara F; Radosevic M; Planagumà J; Soto D; Aguilar E;

(...)

Quirk M; Dai J; Gasull X; Lewis M; Dalmau J .

Referència:
Brain 2020.
Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study

Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R;

(...)

Vanderver A; Graus F; Saiz A; Dalmau J; Spanish Pediatric anti-MOG Study Group.

Referència:
Lancet Neurology 2020.
Reduced serial dependence suggests deficits in synaptic potentiation in anti-NMDAR encephalitis and schizophrenia

Stein, H; Barbosa, J; Rosa-Justicia, M; Prades, L; Morato, A;

(...)

Arino, H; Martinez-Hernandez, E; Castro-Fornieles, J; Dalmau, J; Compte, A.

Referència:
Nature Communications 2020.
Characterization of the sleep disorder of anti-IgLON5 disease

Gaig C; Iranzo A; Cajochen C; Vilaseca I; Embid C;

Dalmau J; Graus F; Santamaria J .

Referència:
Sleep 2019.